Nitrazepam Accord Healthcare (Nitrazepam)

Nitrazepam binds to the benzodiazepine site on the GABA_A receptor, increasing the frequency of chloride channel opening when GABA binds. This amplifies the inhibitory signal, leading to sedation, anxiolysis, muscle relaxation, and anticonvulsant effects.

The appropriate dose of Nitrazepam is determined by the prescribing clinician based on the individual’s condition, age, and response to therapy. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Limited clinical data exist for Nitrazepam use in pregnancy and lactation. Because benzodiazepines can cross the placenta and appear in breast milk, they are generally avoided unless the potential benefit outweighs the risk. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nitrazepam has a relatively long half‑life compared with some short‑acting benzodiazepines, which can provide sustained sleep promotion but may also increase the risk of next‑day sedation. Its potency and duration make it suitable for insomnia, whereas other agents may be preferred for anxiety or procedural sedation.

Nitrazepam tablets should be stored at room temperature, below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Nitrazepam is taken orally, usually as a tablet, with or without food as directed by a healthcare professional. The exact timing (e.g., before bedtime for insomnia) should follow the prescriber’s guidance to achieve the intended therapeutic effect.

Serious risks include respiratory depression, especially when combined with other central nervous system depressants, severe allergic reactions, depression or suicidal thoughts, and the potential for dependence or withdrawal seizures if the medication is stopped abruptly after prolonged use.

Nitrazepam should be avoided in individuals with known hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, or those who are pregnant without a clear medical indication. It is also contraindicated in patients with a history of severe dependence on sedative‑hypnotic drugs.